Search

Sonavex, a TEDCO portfolio company, raises $3 million, preps for national product launch Baltimore's Sonavex Inc. has raised $3 million in new equity funding as it gears up for a nationwide launch of its medical …

TEDCO mention in Baltimore Sun Op Ed We’ll create a $10-billion federal fund, modeled on Maryland’s successful TEDCO fund, to co-invest in entrepreneurs of color, and defer and forgive college loans for Pell-eligible students who start and maintain …

Attila Security, a TEDCO portfolio company, announced its advanced security solutions have achieved the National Information Assurance Partnership (NIAP) Common Criteria certification. Attila Security, a leader in IP security, announced today that two of …

NextStep Robotics' Brad Hennessie shares why he chose to live and grow his TEDCO portfolio company in Maryland. …

Five Female Investors Who Are Making Their Mark in Life Science Arti Santhanam, Ph.D., leads TEDCO’s $5.6M MII fund, which is a program designed to propel research from partner universities towards commercialization MII has had a strong, demonstrable …

Congratulations to Carolyn Yarina of Sisu Global for being named one of Forbes Under 30 for health care! This year, Yarina's company, Sisu Global, launched its first product designed to tackle the problem of chronic blood shortages for transfusions in …

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill 'Superbugs' as Part of Bear's Den Innovation Program Hackensack Meridian Health has invested in the clinical-stage biotechnology company  Adaptive Phage Therapeutics (APT), …

MaxCyte and KSQ Therapeutics announce development & commercialization agreement to enable the advancement of KSQ’s Adoptive Cell Therapy Programs MaxCyte, the global cell-based therapies and life sciences company, and KSQ Therapeutics, a biotechnology …

Quick-Muscle Skeletal – SeV Complete Kit used in Molecular Therapy paper Elixirgen Scientific’s Quick-Muscle™ Skeletal – SeV Complete Kit (QMS-SeV) was used in a paper that was recently published in Molecular Therapy. Dr. Guangbin Xia (University of New …

3D brain organoid generation kit now available from Elixirgen Scientific Elixirgen Scientific’s new kit, Quick-miniBrain™ uses ES/iPSC differentiation to form miniaturized, 3D human brain tissues for drug discovery and toxicity …

CIRM (California Institute for Regenerative Medicine) features Elixirgen Scientific on their blog …

TEDCO Portfolio Company, CoapTech, in the news 'It was a life saver': New London developed device for feeding tube insertions is a world …

Machfu, a TEDCO portfolio company, raises $3.75 million to accelerate industrial IoT CSL Ventures, Blu Ventures, Texas Ventures and Texas Halo Fund lead investment in Machfu’s technology that securely connects critical assets and sensors to modern web …

HeMemics Biotechnologies, Inc, a Rockville-based TEDCO portfolio company, received a $2.5 million investment from AMVI Partners Hememics Biotechnologies Inc. plans to use the investment from AMVI Partners to begin clinical research for FDA submission for …

RoosterBio, a TEDCO portfolio company, expands facility for second time in 2019 Project will support the increasing global need for “off-the-shelf” cell banks and hMSC bioprocess media products as sales continue to …

TEDCO, NIST give four companies funding The Maryland Technology Development Corp. and the National Institute of Standards and Technology awarded four companies a total of $448,000 to develop NIST-licensed technologies for the market, TEDCO announced …

TEDCO reopens apps for Maryland startup funding Maryland Technology Development Corporation (TEDCO) is once again accepting applications from startups seeking investment from several of its funds that were put on hold in the middle of …

The United States Of Venture Capital: The Most Active VC In Each State (including TEDCO's Maryland Venture Fund) …

Adaptive Phage gets $10M from DoD for antibacterial phage therapies The company is developing phage-based therapies designed to target specific bacteria strains, as contrasted with antibiotics, which target multiple types of bacteria. …

New Nanoparticle Therapy Appears More Effective Than Standard Therapy at Treating Aggressive Breast Cancer Experimental Nanoformulation Outperforms FDA-Approved Treatment for Metastatic Breast Cancer, Increasing Survival in Animal Studies …